Publication Name	World Journal of Clinical Oncology
Manuscript ID	115289
Country	Malaysia

Category	Oncology
Manuscript Type	Minireviews
Article Title	Intermittent fasting enhances cancer therapy via autophagy-dependent and independent mechanisms: Evidence and implications
Manuscript Source	Invited Manuscript
All Author List	Mona Mohamed Ibrahim Abdalla, Payal Bhatnagar, Mohd Hazim Bin Zulkaflee, Abdul Malik Sahib Mohammed Irfan and Nabil Eid
Funding Agency and Grant Number
Corresponding Author	Nabil Eid, Associate Professor, MD, PhD, Division of Anatomy, Department of Human Biology, School of Medicine, IMU University, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Malaysia. nabilsaleheid@imu.edu.my
Key Words	Intermittent fasting; Cancer; Chemotherapy; Autophagy; Metabolic diseases; Obesity; Inflammation
Core Tip	Growing evidence indicates that intermittent fasting (IF) can reduce chemotherapy-related toxicity and slow tumor growth in cancer patients through both autophagy-dependent and independent mechanisms. Therefore, IF may represent a promising strategy for cancer prevention and as an adjuvant to cancer therapy. However, there are limitations associated with IF in cancer therapy.
Citation	Abdalla MMI, Bhatnagar P, Zulkaflee MHB, Mohammed Irfan AMS, Eid N. Intermittent fasting enhances cancer therapy via autophagy-dependent and independent mechanisms: Evidence and implications. World J Clin Oncol 2026; In press

Received	2025-10-15 07:04
Peer-Review Started	2025-10-15 07:04
First Decision by Editorial Office Director	2025-10-24 11:07
Return for Revision	2025-10-24 11:07
Revised	2025-10-30 02:43
Publication Fee Transferred
Second Decision by Editor	2026-01-06 02:37
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-01-06 08:07
Articles in Press	2026-01-06 08:07
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com